Profound Medical Corp.
PROF- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001628808
No open-market purchases or sales by Profound Medical Corp. insiders were filed in the last 90 days; 55 institutions reported holding it in 13F filings for Q2 2026, worth $105.8M in total; no superinvestor holds it.
Holders of 5% or more of PROF
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Profound Medical Corp., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Gagnon Securities LLC | 13G/A | 11.20%3.35M shares | – | Jan 23, 20251 filing | Jan 23, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
2 Schedule 13D and 13G filings on Profound Medical Corp., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Jan 23, 20256:38 PM ET | Gagnon Securities LLCand 2 others | 13G/A | 11.20%3.35M shares | – | Dec 31, 2024 | SEC |
| Oct 11, 20249:42 AM ET | Letko, Brosseau & Associates Inc | 13G/A | 4.90%0 shares | –Below 5% | Sep 30, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Profound Medical Corp. shares.
No Form 144 notices for Profound Medical Corp. are on file.